ArticleAnnals of surgical oncology2025
The Transcriptomic Landscapes of Appendiceal Primary and Metastatic Tumors are Distinct.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundImproved understanding about the pathobiology of appendiceal cancers (AC) and resulting metastasis is required for the development of novel treatments. The tumor microenvironment in AC is heterogeneous and incompletely characterized. The objective of this study was to leverage spatial high-plex technology to evaluate the transcriptomic landscape of epithelial and stromal cells in primary AC tumors, adjacent normal appendix, and corresponding peritoneal metastasis.
methodsA tissue microarray (TMA) containing cores from 14 unique patients having matched primary tumor, adjacent normal appendix, and peritoneal metastases was analyzed with digital spatial profiling (NanoString, GeoMx) using pancytokeratin (PCK) to delineate stroma (PCK-) from epithelium (PCK+). Then RNA sequencing was performed to measure transcript abundance separately within the stromal and epithelial compartments.
resultsTranscriptomic analysis demonstrated differences between tumor and stromal compartments in both primary tumor and metastatic sites. Primary and metastatic tumor stroma (PCK-) demonstrated greater expression of ribosomal biogenesis pathways than normal appendiceal tissue. Primary and metastatic tumors were generally similar with respect to transcription. However, within the epithelial compartment (PCK+), peritoneal metastases exhibited upregulated cytoskeletal and collagen metabolism pathways/genes compared with primary tumor.
conclusionsThe study data indicated that although appendiceal peritoneal disease is transcriptionally similar to the primary tumor, potentially important distinctions exist between metastatic and primary disease. Differences appear to be driven predominantly by changes in collagen metabolism at the peritoneal site. A better understanding of both tumor and stromal compartments of metastatic disease will be essential to improving therapeutic options, specifically systemic treatment, which is characteristically ineffective.
Indexed as
Identifiers
39987388What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.